AcelRx Pharmaceuticals financials at a glance

+ Portfolio

The revenue of AcelRx Pharmaceuticals is reported as 0.00065 billion Dollars in the fiscal year 2023. The earnings were -0.39 Dollars per share in 2023, which was 93.28 higher than 2021. And about -0.01759 billion Dollars are reported as free cash flow in the financials of AcelRx Pharmaceuticals 2023. No dividends were paid to the shareholders of the AcelRx Pharmaceuticals stock NasdaqGM:ACRX in the financial year 2023.

$0.65M

Revenue

$-0.39

Earnings Per Share

23.50%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.65

Earnings Per Share

-0.39

Gross Margin %

23.50

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Rev.	Revenue	N/A	$0.65M	$2.82M	$5.42M	$2.29M	$2.15M	$8.00M	$17.36M	$19.26M	$5.22M	$29.50M	$2.39M	$1.07M	$0.00M
GM %	Gross Margin %	0.00%	23.50%	-0.94%	-25.48%	0.00%	0.00%	-,276.09%	-94.26%	-25.93%	0.00%	10.88%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	-21.02%	0.00%	0.00%	0.00%	0.00%	-,184.12%	-99.66%	0.00%	-22.60%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-1.79	$-0.39	$-5.80	$-9.40	$-13.40	$-16.20	$-22.00	$-21.89	$-11.00	$-20.99	$-17.80	$-30.20	$-23.20	$-31.20
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	-0.00%	-0.00%	-0.00%	-0.00%	0	0	0	0	0	0	0
Sha.	Shares	N/AM	16.97M	7.35M	5.95M	4.02M	3.94M	2.54M	2.27M	2.26M	2.19M	2.16M	1.85M	0.98M	0.97M
OCF	Operating Cash Flow	N/A	$-17.49M	$-30.00M	$-38.51M	$-51.18M	$-29.08M	$-29.77M	$-29.40M	$-19.95M	$-34.46M	$-0.49M	$-24.58M	$-15.29M	$-12.23M
FCF	Free Cash Flow	N/A	$-17.59M	$-1,827,030.00M	$-40.36M	$-54.65M	$-29.89M	$-32.17M	$-33.12M	$-21.41M	$-39.96M	$-3.77M	$-25.41M	$-17.31M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.66	$-1.23	$-0.27	$-0.47	$-0.69	$-0.51	$-0.69	$-0.73	$-0.48	$-0.92	$-0.09	$-1.15	$-1.00	$-,372.46

AcelRx Pharmaceuticals financials at a glance

Financials

Discover